Characterization of hereditary transthyretin cardiac amyloidosis in Spain

Autor:	Álvarez Rubio J, Manovel Sánchez AJ, González-Costello J, García-Pavía P, Limeres Freire J, García-Pinilla JM, Zorio Grima E, García-Álvarez A, Valverde Gómez M, Espinosa Castro MÁ, Barge-Caballero G, Gimeno Blanes JR, Bosch Rovira MT, Rincón Díaz LM, Aibar Arregui MÁ, Gallego-Delgado M, Jiménez-Jáimez J, Martínez Moreno M, Basurte M, Arana Achaga X, Hernández Baldomero IF, Ripoll-Vera T, AC-TTRv-Spain Investigator Group
Rok vydání:	2022
Předmět:	Amiloidosis cardiaca Amiloidosis por transtirretina Cardiac amyloidosis Prognosis Pronóstico Transthyretin Transthyretin amyloidosis Transtirretina Tratamiento Treatment cardiovascular system nutritional and metabolic diseases macromolecular substances nervous system diseases
Zdroj:	Revista espanola de cardiologia (English ed.) r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname
ISSN:	1885-5857
Popis:	Hereditary transthyretin amyloidosis (hATTR) is a disease caused by mutations in the transthyretin gene that frequently shows cardiac involvement due to amyloid deposition in the myocardium. Our objective was to identify cardiac involvement in a Spanish cohort.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8ddaa143b806e56c45afa39e9f7f3b49 https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15220 Zobrazit plný text záznamu Full Text from ScienceDirect